 |
 |
 |
 |
 |
|
|
| Article 1 to 6 out of 6 concerning Invitrogen Corporation
|
-
Invitrogen Corporation Announces Strategic Collaboration with Tecan
(06 Mar 2008)
Partnership provides integrated instrumentation and reagent solutions
Invitrogen Corporation and Tecan are entering into a collaboration agreement to validate the compatibility of Invitrogen's reagents with Tecan's microplate detection instruments.Invitrogen's drug discovery products will be validated on selected ...
-
Invitrogen, Agilent Technologies Settle Multiple Patent Litigations
(08 Feb 2008)
Settlement resolves all pending patent litigations between two companies
Invitrogen Corporation (IVGN) and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies. The settlement resolves three patent infringement lawsuits between Invitrogen ...
-
Invitrogen Partners with Cytori to Offer Adipose Stem Cell Research Products
(10 May 2007)
Invitrogen Corporation and Cytori Therapeutics entered into a global strategic supply and commercialization agreement to offer adipose-derived stem cell-based research products to life science researchers. Invitrogen will offer Cytori's stem cell ...
-
Invitrogen Licenses Geron Intellectual Property for Development of Research Tools
(04 Jul 2006)
Invitrogen Corporation and Geron Corporation announced that Invitrogen has licensed Geron intellectual property related to the growth of human embryonic stem cells (hESCs). The agreement provides Invitrogen with a non-exclusive license under Geron's ...
-
Qiagen and Invitrogen Revealed as Top Suppliers in the RNA Purification Market
(30 Jun 2005)
A recent survey reveals that more than 60% of scientists cited Qiagen as their primary supplier of RNA purification kits and more than 45% identified Invitrogen as their primary supplier of commercial reagents. With almost one-third of scientists ...
-
Dynal Biotech: Magnetic Bead Chromatography: No Columns Required
(07 Jun 2005)
Dynal Biotech, a subsidiary of Invitrogen Corporation announced the release of the first two products in its new proteomic preparation range - weak cation exchange (WCX) Dynabeads(r) and reversed phase chromatography (RPC) Dynabeads(r). These novel ...
 |
|
|
|
|